Slashdot Mirror


Toward a 3D Search Engine

Plasma Droid writes "NewScientistTech has a story about a 3D molecular search engine that is over 1,500 times faster than anything previously developed. The researchers, from Oxford University, developed a lightning-fast way to quickly match 3D shapes mathematically. This could not only speed up searches for new drugs, but lead to 3D search engines, for finding objects uploaded to platforms such as Google Earth, they say." The problem will be in jump-starting the supply of 3D data about molecules and everything else.

60 of 83 comments (clear)

  1. Enter Search Term: by LiquidCoooled · · Score: 5, Funny

    Boobies, extra large please.

    --
    liqbase :: faster than paper
  2. WOO HOO! by Lumpy · · Score: 2, Funny

    Finally I can search for Dodecahedron porn!

    --
    Do not look at laser with remaining good eye.
    1. Re:WOO HOO! by Kenja · · Score: 5, Funny

      Hot molecule on molecule action! See uncensored carbon bonding!

      --

      "Have you ever thought about just turning off the TV, sitting down with your kids, and hitting them?"
  3. Shape versus negative space by goombah99 · · Score: 5, Informative

    It's pretty easy to geometrically hash or construct reduced feature vectors for matching. People (like me) have been doing this for years. It's much harder to know if a molecule will fit into a crevice or negative space. THe latter is probably more important to drug design. the reduced feature vectors let you know quickly if two molecules are simmmilar in shape. Which is the title given to the article. But then this is discussed in the context of drug targets. A harder problem. What maybe new or clever here is that they found a very useful set of feature vectors.

    --
    Some drink at the fountain of knowledge. Others just gargle.
    1. Re:Shape versus negative space by Anonymous Coward · · Score: 4, Funny

      It's pretty easy to geometrically hash or construct reduced feature vectors for matching. People (like me) have been doing this for years

      I bet you have to beat the chicks away with a stick.

  4. so? by mastershake_phd · · Score: 1

    Its going to be full of spam in under a year. You cant stop those guys.

    1. Re:so? by Bat+Country · · Score: 2, Funny

      Great, I can finally search for the chemical formula for C14L11S, which honestly has been puzzling me for some time. Apparently it affects the molecule P3N1S.

      --
      The land shall stone them with the bread of his son.
    2. Re:so? by iago-vL · · Score: 2, Funny

      Am I the only one who had to stop and think, "Ok 14 atoms of carbon combined with..... what the hell element is 'L'?"

    3. Re:so? by The+Great+Pretender · · Score: 1

      No, but the 14-year old gamer inside of me quickly burst out, slapped my forehead and set me straight.

      --
      A positive attitude may not solve all your problems, but it will annoy enough people to make it worth the effort.
  5. Impact on Pharma (esp. patents) by Mateo_LeFou · · Score: 4, Interesting

    I've always been of two minds about whether the drug industry was a good example of patents being cost-effective, because I suspect that very good technology will soon emerge that makes pharma R&D less expensive, by making it primarily a data-processing (esp. simulation) issue. Seems like this tech might be the first piece of that puzzle?

    --
    My turnips listen for the soft cry of your love
    1. Re:Impact on Pharma (esp. patents) by ThosLives · · Score: 2, Insightful

      The problem isn't that it takes a while to find new stuff. The problem is the barriers to entry are so high that sufficient competition can't take place, hence there is no pressure to work quickly. Basically the medical industry is *not* a free market.

      Now, I don't think the barriers need to be removed, because most of the high barrier is to ensure that treatments are effective without nasty side effects. About the only part of the barrier I can see being removed is somehow changing the liability laws, but I don't know what would be acceptable.

      --
      "There are a dozen opinions on a matter until you know the truth. Then there is only one." - CS Lewis (paraprhase)
    2. Re:Impact on Pharma (esp. patents) by Red+Flayer · · Score: 2, Insightful

      The problem is the barriers to entry are so high that sufficient competition can't take place, hence there is no pressure to work quickly.

      Except the barriers to entry are mostly not regulatory in nature. As with most advanced R&D-based industries, the barriers are brainpower and equipment. There's plenty of capital out there to handle the hit-and-miss nature of drug design, and the regulatory restrictions on drug production and marketing are not barriers to entry for research.

      IMO, what is truly limiting the pharma industry is profit incentive. Big pharma researches the things that will make them the most money -- which, BTW, are not cures for diseases, but rather treatments for conditions.

      The 'competition' you speak of has nothing to do with R&D of new drugs. Barriers to entry prevent new entrants from producing and selling a commodity good, and new drugs are by no means commodities (patents have a lot to do with that). If you're talking about R&D as a commodity, that's a whole different discussion -- but again, it's brainpower and equipment that are the limiting factors causing the barriers to entry.

      As for incentive to work quickly, that is not the case. There is definitely an incentive to work quickly as there is competition from all the big companies -- look at the COX2 inhibitors that were all the rage as low-side effect NSAIDS a couple years ago until certain really bad interactions manifested. Merck, Schering-Plough, everybody was in the game when the new sub-class was discovered. It was literally a rush to market, which is why the adverse effects weren't recognized until post-phase 4 trials.

      --
      "Trolls they were, but filled with the evil will of their master: a fell race..." -- J.R.R. Tolkien on Olog-hai
    3. Re:Impact on Pharma (esp. patents) by ponos · · Score: 2, Interesting

      IMO, what is truly limiting the pharma industry is profit incentive. Big pharma researches the things that will make them the most money -- which, BTW, are not cures for diseases, but rather treatments for conditions.
      This is not entirely accurate. From a business standpoint, if you sell a cure and your competitor sells a "treatment", you'll erase them from the map. So they would definitely like to "cure" things. However, most of the rich, western people do not suffer from diseases per se, but from "risk factors" like hypertension, diabetes, hypercholesterolemia etc etc. The treatments for these conditions are extremely effective but a cure is almost impossible (unless you manage to install a new pair of kidneys or a new pancreas etc).

      Except the barriers to entry are mostly not regulatory in nature. As with most advanced R&D-based industries, the barriers are brainpower and equipment. There's plenty of capital out there to handle the hit-and-miss nature of drug design, and the regulatory restrictions on drug production and marketing are not barriers to entry for research.

      FDA approval is a regulatory barrier and demands very lengthy, very expensive and time consuming pre-clinical and clinical testing. You can't just stab someone with a syringe full of X just because the computer said it works. You need to go through all proper procedures, including testing in mice, primates, healthy volunteers, otherwise healthy patients (i.e. patients that don't have anything else than the disease you want to treat) and the general patient population. You also have to determine lethal doses, drug interactions with a billion other things (foods? additives? common drugs?), allergic reactions etc etc.

      My point is that the "hit and miss" process is not just a wasted stack of paper or some CPU cycles but a process involving real patients, possible deaths, legal battles. After that you'll need a host of research publications to persuade the medical community, marketing exposure etc. A "miss" is a very, very costly thing. Take Merck and Vioxx for example.

      P.

    4. Re:Impact on Pharma (esp. patents) by Red+Flayer · · Score: 1

      FDA approval is a regulatory barrier and demands very lengthy, very expensive and time consuming pre-clinical and clinical testing.

      But it's not a barrier to entry, since established companies must also comply with FDA regulations. Barriers to entry imply that only new entrants face the the barrier.

      Take Merck and Vioxx for example.
      That is exactly what I was referring to with the COX2 inhibitors... Vioxx is the specific example.

      From a business standpoint, if you sell a cure and your competitor sells a "treatment", you'll erase them from the map. So they would definitely like to "cure" things.
      Recent examples? What is happenig now is that they primarily try to put out a competing product, rather than a cure. It's not about putting your competitor out of business, it's about maximizing your profits. The two are not the same, since again, R&D (and drug products!) are not a commodity good where you maximize profits by removing competitors.

      My point is that the "hit and miss" process is not just a wasted stack of paper or some CPU cycles but a process involving real patients, possible deaths, legal battles.
      Agreed. But patients' lives, legal battles, etc, boil down to fiscal liability and cost... from the business standpoint, which is what the drug companies consider.
      --
      "Trolls they were, but filled with the evil will of their master: a fell race..." -- J.R.R. Tolkien on Olog-hai
  6. I'll bring the Hot Grids by Mateo_LeFou · · Score: 2, Funny

    couldn't resist

    --
    My turnips listen for the soft cry of your love
  7. Good, but just one tiny bit of the problem by filthWisard · · Score: 5, Interesting

    This is a really cool advance when working with molecules you already know the shape of, but it still doesn't get around the problem of what shape a molecule is in the first place. A protein molecule will naturally collapse into the shape with the lowest energy. If there are 100 atoms in the main chain, that's 99 different angles that it could have, that's 99 degrees of freedom. I hear that genetic algorithms are pretty good at finding the most lightly shape though, so this may not be as big a problem as it used to be.

    1. Re:Good, but just one tiny bit of the problem by GMO · · Score: 1

      It's not a protein search engine, it's for small molecules.

      Also, the search space for polypeptides is more restricted than that. There are only so many allowed torsion angles.

    2. Re:Good, but just one tiny bit of the problem by picob · · Score: 2, Interesting

      Usually the aminoacid sequence is known, and you can find structures of similar aminoacid sequences in databases using a BLAST (search algorithms). If that doesn't give a structure of which the structure (preferably from a crystal, otherwise NMR) was determined you can try to predict the protein structure: proteins have domains, small subsequences of which the shape is known. Many domains are known that have a particular shape. If you have determined a few of these then it becomes a lot more easy to determine the rest of the protein.

    3. Re:Good, but just one tiny bit of the problem by illerd · · Score: 1

      Sequence similiarity tends to imply structural similarity. Find another protein with a similar peptide sequence and a known structure, use this structure as your search query, and you've got a pretty good guess of what your protein might look like. Better yet, you've got a good starting point for your hackish protein folding method (monte carlo, genetic algorithm, neural networks, whatever)

    4. Re:Good, but just one tiny bit of the problem by tfoss · · Score: 1
      I hear that genetic algorithms are pretty good at finding the most lightly shape though, so this may not be as big a problem as it used to be.


      They may be *better* at predicting structure, but they are still a shit long way from being any good. Remember that whole big Blue Gene deal, building the biggest baddest computer out there, that was done pretty much to be able to predict protein structure, and (last i heard) they still aren't even close. Every so many years a new technique for prediction comes out (Ohh, threading! *wait x years* Ohh, genetic algorithms! etc etc) with big expectations that works for a few proteins and thats about it.

      -Ted

      --
      -=-=- Quantum physics - the dreams stuff are made of.
  8. Comment removed by account_deleted · · Score: 3, Insightful

    Comment removed based on user account deletion

  9. Re:Problem...? by LordPhantom · · Score: 2, Insightful

    No, that will be a problem. Once you have the database, what exactly am I supposed to input for searching? Will I need to learn how to create a 3D model in order to search for similar objects?
    The rest of your comments are pretty valid, however in this case that would seem to be aside the point. Searching objects in this fashion would be as simple as metadata that is appropriate for 3d model searches. Rather than provide a base model, you could search the metadata supplied with/for/generated for shapes, and once you have a few from the library, use THOSE as searches for -similar- or combined models. It's actually quite possible, if of questionable use - not to mention your criticism could be thrown back at you by simply saying "What!??! A search engine for sound? That will never work, I'd have to learn how to whistle".

  10. Re:Problem...? by drinkypoo · · Score: 1

    No, that will be a problem. Once you have the database, what exactly am I supposed to input for searching? Will I need to learn how to create a 3D model in order to search for similar objects?

    Even if you do, you can use a sketching tool (like google sketchup... mmm, sketchup) to whip out a basic 3d model.

    Also, it could be done through a tree-selection process - where you pick from perhaps 9 images the model that looks the most like the one you want, and you continue in this vein until you find (or don't find) the one you're looking for. I don't know if their software would work well with this approach, though.

    --
    "You're right," Fisheye says. "I should have set it on 'whip' or 'chop.'"
  11. Speed versus Thoroughness by wsherman · · Score: 3, Insightful

    NewScientistTech has a story about a 3D molecular search engine that is over 1,500 times faster than anything previously developed.

    The implication both from the summary and from the article itself is that this new search is just as thorough as other search methods but much faster. To prove thoroughness they would have had to show that anything found by other search methods will also be found by their new, much faster, search method. I doubt very much that they were able to do prove this rigorously.

    That's not to say that the problem of matching 3D molecular shapes is not important or that their research is not valuable. I would say, though, that it is misleading to claim that they have solved the 3D search problem with a much faster algorithm. There are many different measure of 3D similarity and, for many measures of similarity, the only way to guarantee an optimum match is by exhaustive search.

    Note that, in general, every search will be exhaustive in the sense that the query must be compared to every entry in the database. The problem is that many measures of similarity have additional parameters that must be optimized by exhaustive enumeration for each comparison. The classic example is a measure of 3D similarity that pairs each atom in the query with an atom from the structure in the database. In the general case, all possible pairings must be tried through an exhaustive enumeration.

    1. Re:Speed versus Thoroughness by drinkypoo · · Score: 1

      In the general case, all possible pairings must be tried through an exhaustive enumeration.

      Why should that be true? We are able to categorize textual content and build indexes based on word structure. Why couldn't we do the same thing with 3d objects, and thus be able to discard a large number of comparisons up front?

      --
      "You're right," Fisheye says. "I should have set it on 'whip' or 'chop.'"
    2. Re:Speed versus Thoroughness by wsherman · · Score: 1

      In the general case, all possible pairings must be tried through an exhaustive enumeration.
      Why should that be true?

      For some measures of 3D similarity there are shortcuts and for other measures there aren't shortcuts. For example, what happens if part of our query molecule is very similar to part of a molecule in the database we are searching? Does that count as a match or not? If the answer is that it does not count as a match, then we could sort our search database by number of atoms - only those molecules that have the same number of atoms as the query need to be considered. If the answer is that it does count as a match then all parts of our query molecule need to be compared to all parts of of every molecule in the database.

      One of the most common methods for comparing molecules is to pair atoms in the query molecule with atoms in the molecule from the database and then add up some measure of the distance between the pairs of atoms. The most common measure of distance is root mean square (RMS) deviation. The problem with pair-distance similarity measure is that changing even a single pairing can dramatically change the best alignment (i.e. a rotation and a translation). The consequence of this is that the only way to be sure that the best pairings have been found is to try all possible pairings.

      The deeper problem is that it's not clear that a rigid alignment is desirable. Many molecules are quite flexible. In that case, an optimal search would consider all possible pairing and all possible molecular conformations. Obviously, this is quite a large search space. A search algorithm that could find a guaranteed optimal pairing and conformation without exhaustive search would be a huge innovation. That doesn't seem to be what the people in the article have done, though. For that matter, it may even be impossible.

    3. Re:Speed versus Thoroughness by illerd · · Score: 1

      The implication both from the summary and from the article itself is that this new search is just as thorough as other search methods but much faster. To prove thoroughness they would have had to show that anything found by other search methods will also be found by their new, much faster, search method. I doubt very much that they were able to do prove this rigorously.

      ...the only way to guarantee an optimum match is by exhaustive search... I haven't read the paper, but I don't think this (a thorough comparison) is as hard as you think it is. The bioinformatics community is pretty good about sharing datasets and software. There are benchmarks datasets that researchers use for comparing shape-matching techniques. Pick, say, 100 query molecules and a database of 10,000 molecules. Search the database for each query, 1,000,000 queries, multiplied by the number of techniques you're comparing. Not that much work. Throw in Kabsch-style cRMS matching as a ground truth, and you're standing on pretty solid ground. Like I said though, I haven't read it, so who knows if they did this.

      For any difficult optimization problem, there's bound be a hack that works very nicely. Maybe they found the hack.
    4. Re:Speed versus Thoroughness by wsherman · · Score: 1

      I haven't read the paper, but I don't think this (a thorough comparison) is as hard as you think it is.

      What I was referring to was guaranteeing that a particular search method can find the best match. If I understand what you're saying, it may not be that important to guarantee a best match - which is a good point.

      With respect to guaranteeing that a search has found a best match, there are two problems. The first problem is that the search method may not reflect what is actually desired. If you want to find the inhibitor that binds most tightly to an enzyme then find the molecule that has the smallest RMS deviation from a rigid alignment to a known inhibitor may not give the tightest binding. The second problem is that even if you restrict yourself to rigid RMS deviation, the only way to guarantee the best RMS deviation is to use that as your search method.

  12. they got it backwards by oohshiny · · Score: 3, Interesting

    Currently, the most common way to find the 3D shape of a particular molecule within a database is to superimpose a candidate over the query molecule and see how much of it overlaps. But this is time consuming, partly because it requires both molecules to be precisely aligned.

    Yes, that's currently "the most common way" because at least you can tell what you're getting: when you get a match, you can actually say how close the different shapes are to one another.

    The new technique uses a different approach. It analyses the position of the different atoms within a molecule to understand its shape. These relative positions can be mapped and stored a molecular database.

    That's actually not a "new technique", it's an old technique. It's what people used to do before they tried to overlay 3D shapes accurately. They used to do that because computers used to be too slow to do the accurate comparison.

    As the article points out, there is only limited 3D shape information available at all. Few people need to do 3D queries right now, and there is little data to do them on, so optimizing speed is the wrong thing to do; we need to optimize accuracy and scientific relevance.

    1. Re:they got it backwards by oohshiny · · Score: 1

      It's very important for pharamceutical companies.

      I didn't say it wasn't important, I said few people are doing these searches. The reason that's important is because it means that users can generally run this stuff on their desktops for hours, which is a lot more compute power available than, say, for your average web query.

      There are many databases of 3D representations of molecules.

      There are indeed. But the actual number of comparisons you need to do numbers in the thousands, not in the billions, as it is for other kinds of content.

      Here's a little one to play around with (180MB uncompressed)

      That is a negligible amount of data compared to other search tasks. I have 10000 times more text and image data than that sitting around on my desktop alone.

      The fact remains: we don't need ultra-fast 3D comparisons at this point, we need ultra-accurate comparisons, because even ultra-accurate comparisons would be fast enough to solve the 3D search problems people actually have.

  13. Hack the gibson! by Anonymous Coward · · Score: 1, Funny

    We had 3d search engines over a decace ago: http://imdb.com/title/tt0113243/

  14. Not enought structures? by ajax142 · · Score: 4, Insightful
    The author lists an apparent problem of this 3D search as a lack of molecular structures and calls for a "jump start" in the supply of 3D data, I call BS on this claim. A quick look at the Cambridge Structural Database shows 400,977 strucutures of 363,931 different molecules. There are another 89,064 structures of inorganic molecules in the Inorganic Crystal Structure Database. On the biological side there are 3,425 structures of Nucleic Acids in the NDB as well as 42,082 structures of proteins and polypeptides in the PDB. If that still isn't enough for the authors, fire up any number of ab initio quantum chemistry programs and in a short time you can create a library of good guesses for the structure of small molecules.

    I tend to think the authors of the article are refering to the problems of a "useable form" for the structures and easy access of many of these databases. The first problem is mearly a problem of converting between the various structural file formats out there, something a good programmer (or grad student) can solve is a few weeks or less. The second is a bureaucrat issue and not a scientific one.

    1. Re:Not enought structures? by at0mjack · · Score: 1

      No, completely wrong, I'm afraid :). The context here is virtual screening in drug discovery: you either have a protein cavity of known shape or you have a known inhibitor of a protein in an (either known or modelled) bound conformation. The question is "Which other molecules could fit the cavity?". The problem is that molecules are flexible. The average drug-size molecule has 6-10 rotatable bonds, and anywhere from 50 to several thousand different plausible 3D shapes. Crystallographic data from the CSD doesn't help: that tells you what structure each molecule takes up in a solid crystal, which will be completely unrelated to the shape it may adopt inside a protein active site. You mention QM programs: these are still quite a few orders of magnitude too slow to do conformation searches on databases drug-sized molecules. There are programs to do this using classical models, but all of them have issues, and the size of the databases becomes an issue. We (http://www.cresset-bmd.com/) have an in-house database holding up to 50 conformations on 4 million molecules: this is heading towards a terabyte of data and took a reasonable-sized Linux cluster a month to generate. That database is simply all of the compounds you could buy: if you wanted instead to search all compounds you could plausibly make in 2 reactive steps from commercially-available reagents you'd have a database with more than 10^20 compounds.

  15. Lots of 3D bio data out there by ghoti · · Score: 1

    The problem will be in jump-starting the supply of 3D data about molecules and everything else.

    Well the RCSB Protein Data Bank would be a start, and there are tons of molecule data bases with 3D data that are only waiting to be thoroughly mined. The pharmaceutical companies have them, and there are free ones too.

    In fact, the motivation for this research undoubtedly was the abundance of data that is out there but can't/could not be searched efficiently.
    --
    EagerEyes.org: Visualization and Visual Communication
    1. Re:Lots of 3D bio data out there by at0mjack · · Score: 1

      Firstly, only some families of proteins have any x-ray structural data about them: there are whole families that are effectively uncrystallisable.

      Secondly, the protein's 3D shape is only half the battle. Small molecules are generally highly flexible, so to search them in 3D you need to enumerate their potential shapes first. That's not trivial for large sets of compounds.

  16. Re:Problem...? by GMO · · Score: 2, Interesting

    Hmmm. Maybe it depends on whether you can convert from internal coordinates to a 3D structure. What you seem to be suggesting is moving through structure space, matching as you go along.

    So at any point, you have to generate images of the 'neighbours' of the current structure. It could work. Maybe.

  17. Quite interesting by excelsior_gr · · Score: 3, Interesting

    This is quite an interesting achievement. The tools that I am familiar with can only search for 2D structures like functional groups (alcohol groups, aromatic rings, etc). At their best, they might give the ability to search for R- and S- stereoisomers, but that is it. This is pretty enough for tasks like solvent design that are quite frequent in the chemical process industry, but in the pharmaceutical R&D they need more powerful tools.

    I will give a simple example of an enzyme: These nice molecules catalyze reactions of vital importance in the modern pharmaceutical industry by providing a chemical "lock" where the "keys" (i.e. the reacting molecules) will dock on. This enables them to react and form a new molecule that will then undock from the enzume leaving the "lock" free for the next pair.

    These "locks" are actually 3D structures of appropriately aligned molecules. This is where this search ability comes in: The chemist suspects how the appropriate lock would look like for catalyzing his reaction (3D alignment of functional groups), much like someone suspects what the right keywords for a Google search are. Then he feeds the data to the machine and gets the molecules that are likely to be of assistance in his work. After that, he can make experiments testing these enzymes to see if they actually work.

    This should speed things up very much in biochemical research. It means less literature research and less failed experiments.

  18. Ehm... it's how much faster? by lagfest · · Score: 2, Interesting

    So the summary says it's 1500 times faster. OK then, if i double the number of items in the database and compare again, is it still 1500 times faster? What if we do a million times the number of items?

  19. Great by organgtool · · Score: 1

    So now whenever I search for information about caves or black holes, I'll get sent to goatse.

  20. related problem by smellsofbikes · · Score: 2, Interesting

    It's nice to know what shape a molecule is. It would be even nicer to be able to make a molecule in a particular shape. If you map an enzyme's active site -- its topology, charge distribution over the surface, possibility for organometallic or hydrogen bonding -- you have a much better chance of finding some interesting analog to the enzyme's substrate that'll make the system do something new. Even better, you could take an existing molecule that you *want*, and form an enzyme surface so that two cheap molecules, exposed to your new enzyme surface, will find it thermodynamically favorable to become the molecule you want, and suddenly you're in a very profitable business: you can breed chemical engineering factories rather than having to build them.

    This poses a problem, similar to the (unstated) problem posed by the molecular printers in Neal Stephenson's Diamond Age: what happens when this sort of stuff starts to become widely available and people start engineering enzymes or instructing their printers to produce, say, heroin, or TNT? With molecular printers, presumably the first versions would only be able to produce structural stuff: printing bicycles, not martinis. But if we get to the point where we can design enzymes for a desired substrate -> product reaction, we have a real problem because it's all wet chemistry and there isn't an obvious hardware/firmware way to block people making anything their inventive, twisted little minds can come up with.

    Mind you, I think that's great. I miss the days where I could order almost any chemical I wanted without having to wade through masses of paperwork, tracking, and laws intended to ban any drug analog that might have pharma activity. But it is going to have some very exciting side-effects.

    --
    Nostalgia's not what it used to be.
  21. Possible application? by MercBoy · · Score: 2, Interesting

    This makes me wonder if this could evolve to more general purpose 3-D searches, such as facial recognition, searching for a specific shape of car, suspect identification in a crowd based upon a combination of body shape, face, etc.

    1. Re:Possible application? by excelsior_gr · · Score: 1

      I suppose yes. After all, in the article it says that they are looking at the position of specific points in the general 3D structure and check their geometrical characteristics (skewness, relative distances, etc). This is what face-recognition software does in 2D right?

  22. Re:Problem...? by zippthorne · · Score: 1

    fine, hum then. the union of {people who can whistle} and {people who can hum} is quite large. Even if you only consider the subset of each who {would like to find random songs from vague recollections}

    --
    Can you be Even More Awesome?!
  23. Re:I can do that! by drinkypoo · · Score: 1

    That's great! Now if you could just do that 750,000 times in the next fifteen seconds, and tell me which shape in the set is most similar to this thing in my pocket...

    (cue dick size jokes in 3...2...1)

    --
    "You're right," Fisheye says. "I should have set it on 'whip' or 'chop.'"
  24. FFT by gr8_phk · · Score: 1

    OK, so would it be helpful to do a 3D FFT of the density of the space containing the molecule centered at the CG ?? The frequency content is invariant under rotation, and the lowest spatial frequencies should be representative of the overall shape of the molecule. Just asking if you've tried this and how well it worked. It's just off the top of my head, but very old-school for image processing. I also suspect it may have some usefulness in matching molecules with the inverse space of other molecules.

    1. Re:FFT by goombah99 · · Score: 1

      Quick answer: yes variations on FFT have been tired out the wazoo. they are inded very successful for kinds of docking problems.

      --
      Some drink at the fountain of knowledge. Others just gargle.
  25. I don't get it by Pedrito · · Score: 1

    I guess what's unclear is what kinds of molecules they're trying to match. I work part-time in a university lab doing drug research. We synthesize variants of existing molecules and test them for efficacy in various diseases, though we do mostly work on cancer-related drugs. Some of the molecules we work with are very large and very complex. But finding what else is out there isn't genereally that difficult. Molecules are divided into a number of families and families of molecules are generally pretty similar to each other in shape. Searching by family name or for molecular sub-parts, generally works pretty well, I've found.

    But there's a lot more to the chemistry than just the shape of the molecule. When it comes to drugs, you're often looking for something that will bind with a given protein and while shape plays a part in that, the functional groups on the molecule are major drivers in whether or not the molecule will actually do its work.

    They don't really give enough specifics in the article to know how valuable this really is.

  26. Typically by HomelessInLaJolla · · Score: 1

    Proteins are typically characterized through X-ray crystallography. The drawback with X-ray analysis is that the protein must be in a crystallized form--this typically means that millions of occurences of the same protein are crystallized together. The shape that a protein takes such that it can form a crystal may not be the shape that the crystal takes when in the heterogenous solution of a cell. Fesik, at Abbott Laboratories, made ground breaking advances in the realm of solution phase study of the shape of proteins--SAR by NMR analysis. Still concerns remain because the solutions used to lend to NMR analysis are not the same as the heterogenous environment within a cell.

    This creates a much larger problem in drug design. The medicinal chemists design molecules to fit active sites of proteins and enzymes but the shape of that active site is only determined from Xray, NMR, or computer generated lowest energy conformations. It is no surprise then that 3/4 of molecules which are advanced to clinical trials fail efficacy studies: in short, they simply do not work. Looking back it's quite logical that they do not work because they were designed to fit a shape that was not a proper representation of the shape which the protein takes within the actual cells, in vivo.

    Making note of this was usually received with extreme vitriol by the management.

    --
    the NPG electrode was replaced with carbon blac
  27. Great... by The+Orange+Mage · · Score: 2, Funny

    Just what we need...another dimension to lose things in.

  28. Anchoring by HomelessInLaJolla · · Score: 1

    While it is fairly easy to predict the geometric shape of a small molecule the more difficult question is one of alignment. If an entire set of molecules, typified as more than one hundred, is considered then how are all of them aligned in 3D space such that they can be properly fit into the target active site?

    I'm disappointed that I cannot read the actual article. While at Abbott (informally) and while at Battelle (in formal intellectual property documentation), I proposed that a vector (the term "vector " was in my IP release forms) for describing molecules in 3D space based on electronegativity, eletrophilicity, nucleophilicity, entropy (freedom of mation), and bulk (volume).

    --
    the NPG electrode was replaced with carbon blac
  29. really? by GMO · · Score: 2, Insightful

    Although the crystal structure is not the same as the structure in solution, it can't be that far off.

    Crystals are pretty watery, much like the cell. Unless packing contacts are altering the active site, they are unlikely to be much different.

    Also, the bulk of the structure is there to keep the active site residues in a particular orientation.

    Perhaps management vitriol was partially justified? :) Only joking, you may be right. I don't work on drug design, only backbone structure.

    1. Re:really? by HomelessInLaJolla · · Score: 1

      The particular 3D crystalline form can differ even from one recrystallization solvent to another. In extreme cases a different configuration at even one rotatable center may significantly affect the shape of the rest of the protein.

      The hope is that a given protein remains within a particular probability space and that the shape of the active site, refined gradually over millions of years, is highly stable. When 3/4 of drugs entering phase I clinical trials fail efficacy, though, the numbers speak for themselves.

      --
      the NPG electrode was replaced with carbon blac
  30. Distorted Expectations by Jekler · · Score: 1

    It's announcements like these that cause me to ponder just how far behind we are in terms of software development progress.

    Back in 1993 I had a whole suite of MS Flight Simulator programs. (different cities were packaged separately. To the best of my recollection, I had Chicago, New York, LA, and Paris). Obviously the game detail was limited, this was before 3D accelerators, but the buildings were still 3D and key locations had fairly accurate roads. I remember reading in more than one computer magazine that these flight simulators were just the beginning, in 5 years (1998) we'd have 3D maps of the whole world. Looking for directions would be a thing of the past, we'd all have programs that could visually tour every nook and cranny of every location in the world.

    It's astounding that computers were set to have a virtual earth in 1998. It's 14 years after I read those articles and we're not even close. Google Earth, the closest representation of such a vision, is about 1% of the way towards it.

    I'm also reminded of the rise of VRML/3DML back in 1996. There was a site run by Superscape (vwww.com the Virtual World Wide Web), with links to hundreds of 3D web sites. Deployment of the 3D web was imminent! I thought it was the wave of the future, it was just a matter of time and refinement. 11 years later, we've all but tossed VRML/X3D/3DML in the toilet. The progress those technologies have made is absolutely minimal, not what you'd expect as a result of over a decade of work.

    So am I excited about a 3D search engine? Not really. I don't even see it happening in my lifetime, never mind the next few years.

  31. Re:Problem...? by Doctor+Memory · · Score: 1

    No, that will be a problem. Once you have the database, what exactly am I supposed to input for searching? Will I need to learn how to create a 3D model in order to search for similar objects? Depends. Did you have to learn how to spell in order to use a text search engine?

    The people who are going to be using this sort of database are going to already have tools available to create their models. People have been creating MOL and PDB files for quite awhile now, and if there isn't a file converter/importer then I'm sure there will be soon. Plus, researchers often want to just search for things that are similar to something they're already looking at. So what they'll do is take whatever model they're currently playing with, lop off chunks of it, and submit the remaining bit to the search engine to see if they've got anything similar on file. So it's not like anyone's going to have to sit down and drag-n-drop individual atoms until they have their model built up...
    --
    Just junk food for thought...
  32. existing 3D molecule search engine by dr_blurb · · Score: 2, Interesting

    Go to: http://shape.cs.princeton.edu/search.html/ and select "Protein Database" from the drop down list, and enter "random" as the keyword. Next, the "find similar shape" links do full 3D feature vector matching against a database of 16900 protein molecule models, in a fraction of a second. But apparently this new method is "1500 faster than anything previously developed"? Maybe the authors never checked the current 3D shape matching literature?

    1. Re:existing 3D molecule search engine by dr_blurb · · Score: 1

      The link is http://shape.cs.princeton.edu/search.html (without the trailing slash)

    2. Re:existing 3D molecule search engine by at0mjack · · Score: 1

      The Oxford group's technique is looking at a different problem: small molecule 3D shape matching. Surprisingly, this is actually harder than protein shape matching: proteins have a defined 3D shape, but small molecules are flexible and can a variety of shapes. So, you either need to have a flexible fitting method, or you need to enumerate 'example' shapes for each molecule you want to search against.

      Compare your search against ~17K protein structures to a search across the roughly 4 million commercially-available compounds, each with 100 example conformations stored. You can see why algorithm speed becomes an issue.

  33. Crappy reasearch by Anonymous Coward · · Score: 1, Interesting

    Okay I just read the original research article in the royal society. I'm struck by three things 1) the guys who did this are big players in the bussiness 2) the work is startlingly unoriginal and seems to have no reading outside their narrow community in other areas where geometric hashing on moments is routine. 3) They don't even seem to appreciate what is interesting about their own work (the speed--no, all geometric hashes are that fast). But rather the only interesting thing is why their ad hoc, and not particularly imaginative, feature vectors empiricall may beat other proposals. Since they only compare it against some ancient ones one can't really decide if these feature vectors are better or if computers got better since 1992.

  34. Musical pattern searching by smtrembl · · Score: 1

    One thing more important and easier to do than 3d mesh matching is musical pattern matching---like searching on consecutive notes or chords or rythmes. It would be really easy to find a song with relative tone, and music is easy to index and search by interfacing over midi. Is google listening to us, musicians? Simon.

  35. For robots by Anonymous Coward · · Score: 1, Insightful

    Great for robot AI technology. With a couple cameras and some laser equipment, get a good 3D representation of what it's looking at, then run it through the list and find a match.